Elektra Labs, a San Francisco, CA-based healthcare-security company building a platform to review and dispense connected technologies remotely, raised $2.9M in seed funding.
The round was led by Maverick Ventures, with participation from Arkitekt Ventures, Boost VC, Founder Collective, Lux Capital, SV Angel, Village Global and sixteen angels, including founders and CEOs from companies like PillPack, Flatiron Health, National Vision, Shippo, Revel, Verge Genomics and several others.
The new funds will be used to improve infrastructure for the deployment of wearables and connected biosensors.
Led by Andy Coravos, co-founder and CEO, Elektra Labs is a healthcare-security company building a pharmacy for connected technologies (e.g., wearables, biosensors). In addition to the new funding, the company is launching a new product called Atlas, which catalogs connected biometric monitoring technologies that can be used in clinical trials and routine clinical care. The Atlas platform simplifies the evaluation and deployment of connected tools that collect behavioral or physiological measurements.
The company was incubated through the Harvard Launch Lab X and Plug and Play Accelerators, and was awarded a National Science Foundation (NSF) I-Corps grant for its technology.